Industry News
StarLink found in locally-bound food
Traces of the controversial genetically-engineered US corn StarLink have been found in Australia's food matrix. [ + ]
Looking underground for revegetation solutions
CSIRO Plant Industry is helping to 're-green' Australia by using soil bacteria to establish healthier native trees more quickly.
[ + ]Peptech celebrates as US anti-TNF patents secured
Sydney biotech company and antibody specialist Peptech has secured a prize patent for its anti-TNF antibody technology in the United States, the world's most lucrative market. [ + ]
EpiTan names ex-CSL czar as director
Melbourne-based EpiTan has appointed ex-CSL general manager Stanley McLiesh as a non-executive director. [ + ]
GTG joins project to bring wallaby back from the brink
Melbourne biotech company Genetic Technologies has become the sponsor of one of Victoria's most endangered animals, the brush-tailed rock wallaby. [ + ]
Agenix profits up as sales soar
One of Australia oldest biotechs, Agenix Ltd, has produced extraordinary across-the-board results on booming sales of its blood clot diagnostic and infant hygiene products. [ + ]
Cytopia unveils new HQ
Brand new labs on the fifth floor of the Baker Medical Research Institute have become the new home for Melbourne biotech company Cytopia. [ + ]
Contract business boosts Progen revenue
Progen Industries has posted a 58 per cent year-on-year revenue gain, due largely to the performance of its life sciences business, particularly its contract drug manufacturing unit. [ + ]
Peplin rights issue bucks the trend
Listed company Peplin Biotech is proving that requests for fresh funds by young biotechs whose products are far from market-ready aren't receiving an automatic thumbs down from investors. [ + ]
Axon posts loss as revenue slumps
Former share market favorite Axon Instruments has posted after-tax losses of $8.8 million on falling revenues for the half year to June 30. [ + ]
McGauran hopes R&D Start scheme will return in 2003
The return of the Federal government's R&D Start grant scheme may be on the horizon, according to Federal Minister for Science Peter McGauran. [ + ]
Proctor & Gamble to trial Ambri's biosensor
Sydney-based company Ambri has announced that it has entered into an agreement with US consumer products giant Proctor & Gamble. [ + ]
Benitec hires management, gears up to commercialise
Brisbane biotech Benitec has added a managing director and a commercial director to its senior management team, as it prepares to expand its commercialisation activities. [ + ]
New deal suggests FDA approval closer for Gradipore
FDA approval for Sydney-based separation technology company Gradipore has come a step closer, after the signing of a new agreement with Canadian hyperimmune product specialist Cangene. [ + ]
Showcase of scientific research
Some of the dynamic and cutting edge research currently being undertaken at the University of Sydney will be on show late this week and early next week.
[ + ]
